Hosted on MSN1mon
Cantor Fitzgerald maintains Overweight on ORIC stock
O n Monday, Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to ...
ETF Daily News1mon
Cantor Fitzgerald Predicts ORIC FY2025 Earnings
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for ORIC Pharmaceuticals in a report ...
Business Insider1mon
Cantor says Oric accidental release looks ‘very positive’ for mevrometostat
Cantor Fitzgerald notes that the firm discovered ... the high-level news commentary “sounds very positive” for mevrometostat and Oric Pharmaceuticals (ORIC). The firm has an Overweight ...
ORIC Pharmaceuticals (ORIC) Projected to Post Quarterly Earnings on Monday
ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report) is expected to post its quarterly earnings results before the market ...
Yahoo Finance22d
US Senate confirms Cantor Fitzgerald's Lutnick to head Commerce Department
WASHINGTON (Reuters) -The U.S. Senate voted on Tuesday 51-45 to confirm President Donald Trump's nominee Howard Lutnick, the billionaire chairman and CEO of Wall Street firm Cantor Fitzgerald ...
Morningstar22d
Howard Lutnick Confirmed as 41st United States Secretary of Commerce; Steps down from his positions at Cantor Fitzgerald, L.P.
Cantor Fitzgerald & Co. Executive Committee members are Pascal Bandelier, Sage Kelly, Brandon Lutnick, Kyle Lutnick, Stephen Merkel, Danny Salinas, Christian Wall, and Mike Whitaker Brandon ...
Investing1mon
Cantor Fitzgerald maintains Overweight on ORIC stock
On Monday, Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to ...